Skip to content

PTHS PTHS Return on equity

Return on equity at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-29.4%-86.3pp
Journey Medical Corporation logo
Journey Medical CorporationDERM
-36.6%
Opko Health logo
Opko HealthOPK
-16.9%-21.7pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
100.7%+60.3pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
50.2%+36.2pp
HRO
HarrowHROW
-50%+17.5pp

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Debt / equity0.8×
Current ratio2.8×+2.6×